NewBiologix Launches Xcell™ rAAV Production and Analytics Platform to Imp
Precision BioSciences to Participate in Upcoming November Investor Conferen
Attivare Therapeutics Appoints David Sherris, Ph.D. as President, CEO, and
Agilent Presents Solutions Innovation Research Awards to Institut National
Precision BioSciences to Report Third Quarter Results on November 4, 2024
Precision BioSciences to Host Virtual Investor Event Highlighting PBGENE-HB
Precision BioSciences Receives First Approval of Clinical Trial Application
Hesperos and UCF Researchers Develop Human iPSC-Derived Myelination Model,
Etcembly and University of Surrey Launch Pioneering Study to Unlock Next-Ge
Precision BioSciences to Present at the European Society of Gene & Cell The
Shift Bioscience Raises $16M to Advance Cell Simulation AI Platform
BioFuture™ 2024 Tackles the Industry's Critical Challenges and Opportunit
I2Pure Chief Scientist Receives ScholarGPS Highly Ranked Scholar Recognitio
Precision BioSciences to Present at the Upcoming H.C. Wainwright 5th Annual
Tempus Announces Expansion of Collaboration with Takeda to Leverage Multimo
ImmunoPrecise Antibodies Advances Therapeutic Innovation with Groundbreakin
Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Lis
Ray Therapeutics Appoints Christopher Whitmore as Chief Financial Officer
Join Regeneron, IBM, Ipsen and Venture Capitalists at Demy-Colton’s BioFu
Cellino Awarded $25M in Funding from the Advanced Research Projects Agency